Sort
82,697 grants matching “vaccine development”
Identification of the Initial Targets of Transmission
$786,043Thomas Hope · Northwestern University At Chicago · R37 · FY2020 · AI
Translational Geroscience Network
$786,034James L. Kirkland · Mayo Clinic Rochester · R33 · FY2020 · AG
Human Plasma Cell Maturation & Maintenance through CD138, TNFRSF, and Modulation of Ig Secretion
$786,023Frances Eun-Hyung Lee · Emory University · R01 · FY2023 · AI
Preclinical Assessment of a Multi-Head Electroporation Device for Delivery of Bio
$785,889Connie Schmaljohn · Geneva Foundation · R01 · FY2014 · AI
Core B - Technology Core
$785,873Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2024 · AI
Conjugate vaccine impact on pneumococcal carriage, disease, and population geneti
$785,868Jonathan A Finkelstein · Harvard Pilgrim Health Care, Inc. · R01 · FY2011 · AI
Adjuvants for Skin Immunization: Discovery and Mechanisms
$785,860Ioanna Skountzou · Emory University · R01 · FY2016 · AI
A Comprehensive Pre-Natal Intervention to Increase Vaccine Coverage
$785,845Saad B. Omer · Emory University · R01 · FY2016 · AI
A Peptide Nanoparticle Nicotine Vaccine
$785,833Peter Burkhard · University Of Connecticut Storrs · DP1 · FY2012 · DA
Defining HIV reservoirs that rebound following suspension of ART
$785,807Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2020 · AI
Metagenomic Analysis of Arthroplasty Failure
$785,802Robin Patel · Mayo Clinic Rochester · R01 · FY2017 · AR
St. Jude-Memphis Adolescent Trials Unit
$785,800Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2007 · HD
Investigating and identifying the heterogeneity in COVID-19 misinformation exposure on social media among Black and Rural communities to inform precision public health messaging
$785,747Sharath Chandra Guntuku · University Of Pennsylvania · R01 · FY2023 · MD
Enhanced Surveillance-Newly Vaccine Preventable Diseases
$785,744Peter G Szilagyi · University Of Rochester · U01 · FY2007 · IP
New Vaccine Surveillance Network
$785,715John V Williams · University Of Pittsburgh At Pittsburgh · U01 · FY2016 · IP
Enhanced Surveillance for Newly preventable Diseases (ARI and AGE Surveillance) Rochester, NY
$785,715Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2016 · IP
Enhanced Surveillance for New Vaccine Preventable Diseases
$785,715Janet A Englund · Seattle Children'S Hospital · U01 · FY2016 · IP
Stellenbosch University Clinical Trial Unit, Cape Town, South Africa
$785,614Mark Fredric Cotton · Stellenbosch University · UM1 · FY2013 · AI
MHC Variation in Host Response to SARS-CoV2 and COVID-19 Outcomes
$785,611Jill Allison Hollenbach · University Of California, San Francisco · R01 · FY2025 · AI
Host Defense Small Molecule Development for COVID-19 Treatment by Targeting Lysosome
$785,479Yuan Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AI
Combinatorial and computational design of bnAb mRNA vaccines for HIV
$785,418Daniel G Anderson · Massachusetts Institute Of Technology · R61 · FY2023 · AI
MVA Prime/Novel Trimeric Cyclically Permuted Envelope Protein Boost Vaccines for HIV
$785,398Rama Rao Amara · Emory University · R01 · FY2022 · AI
Protective Human Monoclonal Antibodies to HIV-1
$785,373Susan B Zolla-Pazner · New York University School Of Medicine · R01 · FY2009 · HL
Mechanisms of SARS-CoV-2 pathogenesis during HIV/SIV infection
$785,351Megan A O'Connor · University Of Washington · R01 · FY2024 · HL
Allergen Loaded Nanoparticles for Food Allergy Tolerance
$785,246Lonnie D Shea · University Of Michigan At Ann Arbor · R01 · FY2020 · AI